KARYOPHARM THERAPEUTICS ($KPTI) posted quarterly earnings results on Wednesday, February 19th. The company reported earnings of -$0.24 per share, beating estimates of -$0.27 by $0.03. The company also reported revenue of $30,540,000, missing estimates of $35,561,861 by $-5,021,861.
You can see Quiver Quantitative's $KPTI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
KARYOPHARM THERAPEUTICS Insider Trading Activity
KARYOPHARM THERAPEUTICS insiders have traded $KPTI stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $KPTI stock by insiders over the last 6 months:
- RICHARD A. PAULSON (President and CEO) has made 0 purchases and 6 sales selling 22,723 shares for an estimated $17,936.
- MICHAEL MASON (EVP, CFO & Treasurer) sold 7,050 shares for an estimated $5,088
- SOHANYA ROSHAN CHENG (EVP & Chief Commercial Officer) sold 5,356 shares for an estimated $3,865
- MICHAEL MANO (SVP, General Counsel&Secretary) sold 3,971 shares for an estimated $2,866
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
KARYOPHARM THERAPEUTICS Hedge Fund Activity
We have seen 30 institutional investors add shares of KARYOPHARM THERAPEUTICS stock to their portfolio, and 69 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EVERSEPT PARTNERS, LP removed 3,459,123 shares (-62.4%) from their portfolio in Q4 2024, for an estimated $2,339,404
- MORGAN STANLEY added 3,389,541 shares (+2741.3%) to their portfolio in Q4 2024, for an estimated $2,292,346
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 2,000,000 shares (+46.3%) to their portfolio in Q4 2024, for an estimated $1,352,600
- OPALEYE MANAGEMENT INC. removed 1,425,000 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $1,182,750
- ALPHACENTRIC ADVISORS LLC removed 1,125,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $760,837
- JPMORGAN CHASE & CO removed 1,109,516 shares (-80.1%) from their portfolio in Q4 2024, for an estimated $750,365
- D. E. SHAW & CO., INC. removed 817,711 shares (-78.1%) from their portfolio in Q4 2024, for an estimated $553,017
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
